Markets Edge

ReadingSpecialty pharma consolidation now runs on cash reserves, not equity. Founders in late-stage fundraising saw their ask price re-set downward yesterday.

Reading13F filings are historical snapshots. By the time they're public, the real capital has already shifted. Watch who follows Mandel in the next 48 hours.

ReadingLiquid cooling is now table stakes for hyperscale. Suppliers without proprietary thermal tech get commoditized inside 18 months. The acquisition is a race against that clock.

ReadingIndia's fintech lending cohort is in capital efficiency phase, not acquisition phase. The IPO validates that lenders now compete on unit economics, not top-line velocity.

ReadingA $200M buyback on a market cap under $800M is aggressive defensiveness. Management is pricing itself out of acquisition range, not into it.

ReadingWhen IPO calendars compress, it's because underwriters are front-running sentiment. The next three months will determine if the window stays open or slams shut.

ReadingFaster tender timelines reward strategic buyers who move decisively. Financial sponsors and competitors now have less time to counter-offer. The change tilts toward control, not competition.